CEN Case Reports

, Volume 7, Issue 1, pp 94–97 | Cite as

A novel heterozygous GLI2 mutation in a patient with congenital urethral stricture and renal hypoplasia/dysplasia leading to end-stage renal failure

  • Toshihiko Shirakawa
  • Yumiko Nakashima
  • Satoshi Watanabe
  • Sadatomo Harada
  • Mariko Kinoshita
  • Toshiharu Kihara
  • Yuko Hamasaki
  • Seiichiro Shishido
  • Koh-ichiro Yoshiura
  • Hiroyuki Moriuchi
  • Sumito Dateki
Case Report
  • 67 Downloads

Abstract

Glioblastoma 2 (GLI2) is a mediator of Sonic hedgehog signaling pathway that plays an important role in development of the central nervous system and limbs. Heterozygous GLI2 mutations have been associated with postaxial polydactyly, various pituitary dysfunction, and holoprosencephaly-like phenotype. Herein, we report a Japanese boy who presented with isolated growth hormone deficiency with ectopic posterior pituitary, postaxial polydactyly, atrioventricular septal defect, intellectual disability and dysmorphic facial features including mid-facial hypoplasia. The patient was also complicated with congenital urethral stricture with megacystis, hydronephrosis, and renal hypoplasia/dysplasia, which led to end-stage renal failure by the age of 8 years. Trio-whole-exome sequencing showed a novel de novo heterozygous frameshift mutation in GLI2 (c.3369delG, p.Met1123Ilefs*7) in the patient. This is the first report of possible association between GLI2 mutation and the phenotype of congenital anomalies of the kidney and urinary tract, and subsequent end-stage renal failure. Further studies on the urogenital phenotype in patients with GLI2 mutations may clarify a role of GLI2 in embryonic development of the urinary tract.

Keywords

GLI2 CAKUT Urethral stricture Renal failure Polydactyly GH deficiency 

Notes

Acknowledgements

We thank the patient and their family who participated in this study. This work was supported by a Grant for the Initiative on Rare and Undiagnosed Diseases in Pediatrics (no. 15gk0110012h0101) from the Japan Agency for Medical Research and Development (AMED), Tokyo, Japan.

Compliance with ethical standards

Conflict of interest

Yuko Hamasaki belongs to a department endowed with sponsorship by Asahi Kasei Pharma Corporation, Novartis Pharma K.K., Chugai Pharmaceutical Co., and Astellas Pharma. The other authors have declared that no Conflict of interest exists.

Human and animal rights

All procedures performed in this study involving human participants were in accordance with the ethical standards of the Institutional Review Board at Nagasaki University Graduate School of Biomedical Sciences at which the study was conducted (IRB approval number 151027331) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Written informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    Ruiz i Altaba A, Palma V, Dahmane N. Hedgehog-Gli signalling and the growth of the brain. Nat Rev Neurosci. 2002;3:24–33.CrossRefPubMedGoogle Scholar
  2. 2.
    Roessler E, Du YZ, Mullor JL, Casas E, Allen WP, Gillessen-Kaesbach G, Roeder ER, Ming JE, Ruiz i Altaba A, Muenke M. Loss-of-function mutations in the human GLI2 gene are associated with pituitary anomalies and holoprosencephaly-like features. Proc Natl Acad Sci USA. 2003;100:13424–9.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Arnhold IJ, França MM, Carvalho LR, Mendonca BB, Jorge AA. Role of GLI2 in hypopituitarism phenotype. J Mol Endocrinol. 2015;54:R141–R50.CrossRefPubMedGoogle Scholar
  4. 4.
    Walker KA, Bertram JF. Kidney development: core curriculum. Am J Kidney Dis. 2011;57:948–58.CrossRefPubMedGoogle Scholar
  5. 5.
    Vivante A, Hildebrandt F. Exploring the genetic basis of early-onset chronic kidney disease. Nat Rev Nephrol. 2016;12:133–46.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Holbrook JA, Neu-Yilik G, Hentze MW, Kulozik AE. Nonsense-mediated decay approaches the clinic. Nat Genet. 2004;36:801–8.CrossRefPubMedGoogle Scholar
  7. 7.
    Bear KA, Solomon BD, Antonini S, Arnhold IJ, França MM, Gerkes EH, Grange DK, Hadley DW, Jääskeläinen J, Paulo SS, Rump P, Stratakis CA, Thompson EM, Willis M, Winder TL, Jorge AA, Roessler E, Muenke M. Pathogenic mutations in GLI2 cause a specific phenotype that is distinct from holoprosencephaly. J Med Genet. 2014;51:413–8.CrossRefPubMedGoogle Scholar
  8. 8.
    Miyagawa S, Matsumaru D, Murashima A, Omori A, Satoh Y, Haraguchi R, Motoyama J, Iguchi T, Nakagata N, Hui CC, Yamada G. The role of sonic hedgehog-Gli2 pathway in the masculinization of external genitalia. Endocrinology. 2011;152:2894–903.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Samnakay N, Orford J, Barker A, Charles A, Terry P, Newnham J, Moss T. Timing of morphologic and apoptotic changes in the sheep fetal kidney in response to bladder outflow obstruction. J Pediatr Urol. 2006;2:216–24.CrossRefPubMedGoogle Scholar
  10. 10.
    Haecker FM, Wehrmann M, Hacker HW, Stuhldreier G, von Schweinitz D. Renal dysplasia in children with posterior urethral valves: a primary or secondary malformation? Pediatr Surg Int. 2002;18:119–22.CrossRefPubMedGoogle Scholar
  11. 11.
    Kitagawa H, Pringle KC, Koike J, Zuccollo J, Nakada K. Different phenotypes of dysplastic kidney in obstructive uropathy in fetal lambs. J Pediatr Surg. 2001;36:1698–703.CrossRefPubMedGoogle Scholar
  12. 12.
    Becker A, Baum M. Obstructive uropathy. Early Hum Dev. 2006;82:15–22.CrossRefPubMedGoogle Scholar

Copyright information

© Japanese Society of Nephrology 2018

Authors and Affiliations

  • Toshihiko Shirakawa
    • 1
  • Yumiko Nakashima
    • 1
  • Satoshi Watanabe
    • 1
  • Sadatomo Harada
    • 1
  • Mariko Kinoshita
    • 1
  • Toshiharu Kihara
    • 2
  • Yuko Hamasaki
    • 3
  • Seiichiro Shishido
    • 3
  • Koh-ichiro Yoshiura
    • 4
  • Hiroyuki Moriuchi
    • 1
    • 5
  • Sumito Dateki
    • 1
    • 5
  1. 1.Department of PediatricsNagasaki University HospitalNagasakiJapan
  2. 2.Department of UrologyNagasaki University Graduate School of Biomedical SciencesNagasakiJapan
  3. 3.Department of Pediatric NephrologyToho University Faculty of MedicineTokyoJapan
  4. 4.Department of Human GeneticsNagasaki University Graduate School of Biomedical SciencesNagasakiJapan
  5. 5.Department of PediatricsNagasaki University Graduate School of Biomedical SciencesNagasakiJapan

Personalised recommendations